ArticleCancer management and research2020

Monitoring Value of Serum HER2 as a Predictive Biomarker in Patients with Metastatic Breast Cancer.

Pengyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.